Pioneer Wound Healing and Lymphoedema Centres’ Post

📢 Exciting News! 📢 I am thrilled to announce that our research paper, "Effectiveness of a training program on the knowledge and awareness of antimicrobial resistance and stewardship among dental house-surgeons", has been officially published in the Public Health & Toxicology journal! This study was a collaborative effort with my esteemed professor & colleagues Dr. Venkitachalam Ramanarayanan, Dr. Akarsha Sundareswaran, and Dr. Dona Boban, focusing on the urgent issue of antimicrobial resistance (AMR) and the crucial role of educational interventions in combating it among dental interns. Our findings highlight the positive impact of targeted educational modules on the attitudes towards AMR, though there is still work to be done in translating knowledge into practice. This publication is a step forward in our commitment to enhancing awareness and fostering better prescribing practices among future dental professionals. Read the full study here: https://lnkd.in/gXDqy2U9 Thank you to everyone who supported and contributed to this research. Let’s continue to work together to address this global health threat! #Research #PublicHealth #AntimicrobialResistance #DentalEducation #Healthcare #Teamwork #Published

Compounded semaglutide can trigger side effects ranging from nausea to pancreatitis. This guide covers recognizing and mitigating adverse reactions through dosage regulation under medical guidance. https://lnkd.in/g8C_fgw7  #semaglutidecompoundinjection

Delighted to announce the International Society on Thrombosis and Haemostasis (ISTH) study on optimizing patient care in managing Heparin-Induced Thrombocytopenia (HIT)! Our collaborative research, conducted over 3 years through Harvard Medical School’s Brigham and Women's Hospital, underscores the critical role of electronic health record (EHR) interventions in improving diagnosis + treatment protocols. HIT presents significant clinical challenges, impacting patient outcomes. Through a rigorous quality improvement initiative, we developed and implemented 3 EHR-based interventions at our 750-bed academic medical center. Noteworthy outcomes include increased appropriateness of heparin-PF4 test ordering and enhanced adherence to guideline-based care delivery. I thank God, my esteemed co-authors, and my mentors for their unwavering support. As I approach commencement next week, I am ecstatic to enter the biopharmaceutical industry post-doctorate. This project has been gratifying as I was the sole student involved, highlighting the invaluable experiential learning opportunities provided by the Brigham and Women's Hospital. Here's to leveraging research for positive healthcare outcomes and continued dedication to advancing the medical field! Dr. Mark Akladious 🖤 🕊️😇 #HealthcareInnovation #HIT #Medicine #Pharmacy #MedicalResearch #GraduationJourney

Nice opportunity to register below and understand how to optimize patient throughout with Surgical Pleth Index (SPI) and Entropy monitoring and its related clinical evidence

I invite you to read this article on the great work of Professor Andreas Kalcker and his foundation https://lnkd.in/dWn3HfCP #alternativemedicine #holisticmedicine #newagemedicine

🌟New ACG Guidelines Update on H. Pylori Tx🌟 The American College of Gastroenterology now recommends: ✅ First-line Therapy: Bismuth Quadruple Therapy (14 days) for treatment-naive patients, and those who failed to eradicate H. pylori with PPI-clarithromycin triple therapy. due to rising antibiotic resistance. ✅ Alternatives: Rifabutin triple therapy and PCAB-Amoxicillin dual therapy are acceptable alternatives, though based on moderate-low quality evidence. 💡PPI-clarithromycin triple therapy should not be used unless antibiotic sensitivity has been performed and demonstrated clarithromycin-sensitivity.

Check out this new interview of The Dose: Clinical Insights for Pharmacists by Meagan Brixie! Hear from Meagan as she chats with Dr. Yu about the evolving treatment landscape, the role of biologic therapy in improving patient QoL, and more! Follow Meagan's LinkedIn profile to stay up to date on her new series! #thedose #Pharmacy #PTCE #Education

A D-dimer test is a blood test that measures the presence of D-dimer, a protein fragment produced when a blood clot dissolves in the body. This test is particularly useful for diagnosing conditions related to abnormal blood clotting. 🌟 Key Points About the D-Dimer Test: 1. Purpose: - The D-dimer test helps determine if you have a blood clotting condition. High levels of D-dimer in the blood can indicate the presence of an abnormal blood clot, but it doesn't specify the type or location of the clot¹. 2. How It Works: - When a blood clot forms, the body produces fibrin, a protein that helps stabilize the clot. Once the clot is no longer needed, the body breaks it down using an enzyme called plasmin, resulting in fibrin degradation products, including D-dimer¹. 3. Conditions Diagnosed: - The test is commonly used to diagnose conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and disseminated intravascular coagulation (DIC)¹. 4. Age-Adjusted D-Dimer: - For patients over 50, an age-adjusted D-dimer cutoff can be used to improve the test's accuracy in ruling out venous thromboembolism (VTE). This adjustment helps account for naturally higher D-dimer levels in older adults². 5. Interpretation of Results: - A positive or elevated D-dimer result suggests significant clot formation and breakdown in the body, warranting further tests or imaging to confirm the diagnosis¹. 🩺 Clinical Use: - Emergency Situations: - In emergency settings, the D-dimer test is often used to quickly assess the likelihood of a blood clot, guiding further diagnostic steps². - Monitoring: - It can also be used to monitor the effectiveness of treatment for clotting disorders and to check for recurrence of clots¹. Understanding the role of the D-dimer test in diagnosing and managing blood clotting conditions is crucial for effective medical care. If you have any concerns about blood clots or related symptoms, consult your healthcare provider for appropriate testing and guidance. #DDimer #MedicalDiagnostics #Healthcare #BloodClots #ClinicalTesting #MedicalLaboratoryTechnology #Microbiology #Phlebotomy #LaboratoryTesting #DiagnosticTesting #HealthcareProfessional #MedicalTesting #ClinicalLaboratory #BiomedicalScience #HealthcareIndustry #MedicalScience #LaboratoryMedicine #ClinicalMicrobiology #InfectionControl #PhlebotomyTechnician #MedicalLabTechnician #MicrobiologyLab #ClinicalLab #HealthcareCareer #MedicalCareer #ScienceCareer #COVID19Testing #Virology #Bacteriology #Parasitology #MolecularDiagnosis #GeneticTesting #Cytology #Histopathology #Immunology #Serology Source: 1) D-Dimer Test: What It Is, What It Is Used For, Risks & Results. https://lnkd.in/detJVkWv. (2) Age-Adjusted D-dimer for Venous Thromboembolism (VTE) - MDCalc. https://lnkd.in/dceUPXc8.

Coding Clarified Medical Terminology Word of the Day! Celiac disease ce·li·ac dis·ease A chronic hereditary intestinal disorder in which an inability to absorb the gliadin portion of gluten results in the gliadin triggering an immune response that damages the intestinal mucosa Celiac disease is a digestive disease that occurs when the immune system reacts to gluten. Symptoms include: Inflammation of the small intestine Loss of microvilli structure Failed intestinal absorption Malnutrition Diarrhea Steatorrhea Nutritional and vitamin deficiencies ICD-10-CM diagnosis code for celiac disease is K90.0 Applicable To Celiac disease with steatorrhea Celiac gluten-sensitive enteropathy Nontropical sprue Use Additional code for associated disorders including: dermatitis herpetiformis (L13.0) Other ICD-10-CM diagnosis codes related to celiac disease include: S35.219A: Unspecified injury of the celiac artery S35.218: Other injury of the celiac artery S35.212: Major laceration of the celiac artery Z13.811: Encounter for screening for lower gastrointestinal disorder K90.41: Non-celiac gluten sensitivit #codingclarified #medicalcoding #cpc #medicalterminology

🚀 𝗕𝗿𝗲𝗮𝗸𝗶𝗻𝗴 𝗡𝗲𝘄𝘀: 𝗨𝗞 𝗡𝗜𝗖𝗘 𝗚𝘂𝗶𝗱𝗮𝗻𝗰𝗲 𝗼𝗻 𝗖𝗹𝗼𝗽𝗶𝗱𝗼𝗴𝗿𝗲𝗹 𝗮𝗻𝗱 𝗖𝗬𝗣2𝗖19 𝗥𝗲𝗹𝗲𝗮𝘀𝗲𝗱! In my 18 years as a pharmacist, I haven't been this excited about a guidance to publish. This update focuses on how CYP2C19 affects only clopidogrel, but it also relates to PPIs, some antidepressants, and voriconazole. It's a very informative resource, check it out! However, it only recommends testing for those who just had a stroke or TIA, not for people already taking clopidogrel. I'm happy to see pharmacogenomics getting more attention in the UK. I am an intermediate metabolizer for CYP2C19—do you know yours?🤔 🔍 Let's talk about how this impacts our practice and patient care!